Bank Of America Sees Stericycle Inc As Attractive Alternative To Traditional Health Care Stocks

In a report published Tuesday, Bank of America analyst Erin E. Wilson reiterated a Buy rating and $126.00 price target on

. In the report, Bank of America noted, “The US Department of Transportation's Pipeline and Hazardous Materials Safety Administration (PHMSA) has issued a special permit to SRCL, allowing for the transport and treatment of Category A infectious Ebola-contaminated medical waste, currently a concern in Dallas, Texas where an Ebola patient is being treated. Given the isolated disease threat at this point in time, we do not anticipate a material financial impact, and we are making no changes to our model. However, the news underscores SRCL's value proposition as the global leader in medical waste management, which should help to instill greater enthusiasm for the shares.” Stericycle closed on Monday at $117.94.